John Barstis

443 total citations
13 papers, 355 citations indexed

About

John Barstis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, John Barstis has authored 13 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in John Barstis's work include Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). John Barstis is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). John Barstis collaborates with scholars based in United States. John Barstis's co-authors include Glenn Mills, Michael C. Perry, Sreenivasa Nattam, Chandra P. Belani, David Rinaldi, Ray H. Clark, Renato V. La Rocca, Barbara D. Florentine, Dennis J. Slamon and Jeffrey J. Raizer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

John Barstis

13 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Barstis United States 8 253 211 52 48 43 13 355
Keita Uchino Japan 12 215 0.8× 151 0.7× 59 1.1× 39 0.8× 86 2.0× 40 357
Chaitali Nangia United States 9 197 0.8× 158 0.7× 55 1.1× 43 0.9× 77 1.8× 34 330
Ignazio Martellucci Italy 11 280 1.1× 110 0.5× 43 0.8× 73 1.5× 64 1.5× 16 356
Maria Rosaria Diadema Italy 8 273 1.1× 188 0.9× 105 2.0× 54 1.1× 68 1.6× 10 406
Kageaki Watanabe Japan 10 288 1.1× 211 1.0× 28 0.5× 34 0.7× 52 1.2× 47 406
Ji Hyun Park South Korea 8 123 0.5× 146 0.7× 60 1.2× 36 0.8× 62 1.4× 22 307
Josefina Cruz Jurado Spain 9 131 0.5× 175 0.8× 37 0.7× 47 1.0× 103 2.4× 37 277
Kaoru Irisa Japan 9 214 0.8× 236 1.1× 24 0.5× 48 1.0× 76 1.8× 16 333
Salma Alam United Kingdom 10 143 0.6× 160 0.8× 53 1.0× 86 1.8× 91 2.1× 14 332
Yoshiro Nakahara Japan 12 282 1.1× 255 1.2× 23 0.4× 54 1.1× 55 1.3× 42 414

Countries citing papers authored by John Barstis

Since Specialization
Citations

This map shows the geographic impact of John Barstis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Barstis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Barstis more than expected).

Fields of papers citing papers by John Barstis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Barstis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Barstis. The network helps show where John Barstis may publish in the future.

Co-authorship network of co-authors of John Barstis

This figure shows the co-authorship network connecting the top 25 collaborators of John Barstis. A scholar is included among the top collaborators of John Barstis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Barstis. John Barstis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lu, Nu T., et al.. (2015). Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient. Journal for ImmunoTherapy of Cancer. 3(1). 41–41. 31 indexed citations
2.
Hurvitz, Sara A., Mark D. Pegram, David W. Chan, et al.. (2009). Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer.. Cancer Research. 69(24_Supplement). 6094–6094. 37 indexed citations
3.
Florentine, Barbara D., et al.. (2008). Breast-Conservation Treatment Outcomes: A Community Hospital’s Experience. The Breast Journal. 15(1). 76–84. 3 indexed citations
4.
5.
6.
Florentine, Barbara D., et al.. (2006). The reliability of fine‐needle aspiration biopsy as the initial diagnostic procedure for palpable masses. Cancer. 107(2). 406–416. 50 indexed citations
7.
Ramalingam, Suresh S., John Barstis, Michael C. Perry, et al.. (2006). Treatment of Elderly Non–small Cell Lung Cancer Patients with Three Different Schedules of Weekly Paclitaxel in Combination with Carboplatin: Subanalysis of a Randomized Trial. Journal of Thoracic Oncology. 1(3). 240–244. 15 indexed citations
8.
Barstis, John, et al.. (2005). Myelopathy After Radiation Therapy and Chemotherapy with Capecitabine and Gemcitabine. Cancer Investigation. 23(7). 596–598. 2 indexed citations
9.
Belani, Chandra P., John Barstis, R. V. Larocca, et al.. (2005). O-093 Meta-analysis of weekly paclitaxel as maintenance therapy foradvanced non-small cell lung cancer (NSCLC) patients following intitial chemotherapy. Lung Cancer. 49. S33–S33. 2 indexed citations
10.
11.
Belani, Chandra P., John Barstis, Michael C. Perry, et al.. (2003). Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation. Journal of Clinical Oncology. 21(15). 2933–2939. 174 indexed citations
12.
13.
Barstis, John, et al.. (1981). Increased inactive creatine kinase B protein in the plasma of patients with malignancy.. Clinical Chemistry. 27(10). 1724–1728. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keita Uchino Breakdown of academic impact, for papers by Chaitali Nangia Breakdown of academic impact, for papers by Ignazio Martellucci Breakdown of academic impact, for papers by Maria Rosaria Diadema Breakdown of academic impact, for papers by Kageaki Watanabe Breakdown of academic impact, for papers by Ji Hyun Park Breakdown of academic impact, for papers by Josefina Cruz Jurado Breakdown of academic impact, for papers by Kaoru Irisa Breakdown of academic impact, for papers by Salma Alam Breakdown of academic impact, for papers by Yoshiro Nakahara
Rankless by CCL
2026